The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency ...

As healthcare organizations navigate large-scale EHR transitions in 2025, patient access is gaining renewed attention, not ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM – Research Report) and Amgen (AMGN – Research ...

Shares of Pfizer Inc. PFE slipped 4.00% to $21.59 Thursday, on what proved to be an all-around dismal trading session for the ...

What Happened? A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

TPG’s Joel Thickins said Five Good Friends’ mission closely aligned with the firm’s focus on backing tech-enabled businesses with the ability to improve healthcare outcomes. When the ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit ... after key FDA official ousted as Trump plans health overhaul Shares of U.S. drugmakers fell on ...